Cost-effectiveness analysis of PCI in focal and diffuse coronary artery disease

被引：0
|
作者：
Munhoz, D. M. [1 ]
Hlatky, M. [2 ]
Collison, D. [3 ]
Berry, C. [4 ]
Oldroy, K. [3 ]
Mizukami, T. [5 ]
Sakai, K. [5 ]
Storozhenko, T. [1 ]
Seki, R. [1 ]
Bouisset, F. [1 ]
Sonck, J. [1 ]
De Bruyne, B. [1 ]
Collet, C. [1 ]
机构：
[1] Cardiovasc Res Ctr Aalst, Aalst, Belgium
[2] Stanford Univ, Sch Med, Stanford, CA USA
[3] Golden Jubilee Natl Hosp, West Scotland Reg Heart & Lung Ctr, Clydebank, Scotland
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Showa Univ, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN SPAIN
    Gonzalez-Juanatey, J. R.
    Gomez, J. J.
    Lozano, F. S.
    Valle, A.
    Bowrin, K.
    Briere, J. B.
    Llorac, A.
    Millier, A.
    de Miguel, C.
    Diana, N.
    VALUE IN HEALTH, 2020, 23 : S493 - S494
  • [42] Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands
    Spoorendonk, J. A.
    Briere, J-B
    Bowrin, K.
    Millier, A.
    Coppens, M.
    Tempelaar, S.
    Verheggen, B.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1231 - 1239
  • [43] Probabilistic modelling of the cost-effectiveness of myocardial perfusion scintigraphy in coronary artery disease
    Underwood, S. R.
    Barwell, A.
    Basu, S.
    Chambers, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 528 - 529
  • [44] Cost-effectiveness comparison of the most common diagnostic modalities in coronary artery disease
    Dewey, M
    Hamm, B
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (25-26) : 1415 - 1419
  • [45] An educational tool to illustrate cost-effectiveness in diagnostic pathways for - Coronary artery disease
    Jacklin, PB
    West, PA
    Sariklis, D
    Beech, R
    Maisey, MN
    M D COMPUTING, 2000, 17 (01): : 49 - 57
  • [46] A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in Sweden
    Doyle, JJ
    McGuire, A
    Arocho, R
    Arikian, S
    Casciano, J
    Svangren, P
    Casciano, R
    Kim, R
    Kugel, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (02) : 76 - 81
  • [47] EVALUATION OF THE COST-EFFECTIVENESS OF DIFFERENT THERAPEUTIC STRATEGIES IN CORONARY-ARTERY DISEASE
    ROQUEBRUNE, JP
    LHERITIER, P
    GIBELIN, P
    BAUDOUY, M
    CAMOUS, JP
    BLANC, P
    BOSSAN, S
    MORAND, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1992, 85 (02): : 239 - 244
  • [48] Comment concerning 'Cost-effectiveness of an invasive strategy in unstable coronary artery disease'
    Möller, BH
    EUROPEAN HEART JOURNAL, 2002, 23 (20) : 1634 - 1634
  • [49] Cost-effectiveness of coronary artery bypass surgery in octogenarians
    Sollano, JA
    Rose, EA
    Williams, DL
    Thornton, B
    Quint, E
    Apfelbaum, M
    Wasserman, H
    Cannavale, GA
    Smith, CR
    Reemtsma, K
    Greene, RJ
    ANNALS OF SURGERY, 1998, 228 (03) : 297 - 304
  • [50] COST-EFFECTIVENESS OF CORONARY ARTERY BYPASS GRAFTING (CABG) VERSUS PERCUTANEOUS CORONARY INTERVENTION (PCI) IN SEVERE STABLE ISCHEMIC CARDIOMYOPATHY: A COMPARATIVE ANALYSIS
    Fatima, Shumail
    Hickey, Gavin W.
    Smith, Kenneth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 713 - 713
12345